9.910USD-0.10%Mkt Cap: 84.03M USDP/E: —Last update: 2026-05-26
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap84.03M USD
Enterprise Value79.42M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-9.16M USD
Revenue/Share—
Last Price9.910 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees32
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-8.05
EV/Revenue—
P/S—
P/B52.22
EPS (TTM)-1.15
EPS (Forward)—
52W Range
7.08025% of range18.40
52W High18.40 USD
52W Low7.080 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-269.59%
ROA-153.37%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.50M USD
CapEx (TTM)169.92K USD
FCF Margin—
FCF Yield-4.71%
Net Debt-279.68K USD
Net Debt/EBITDA0.03
Balance Sheet
Debt/Equity0.37
Current Ratio1.32
Quick Ratio1.10
Book Value/Sh0.1800 USD
Cash/Share0.1700 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.8.48M
Float6.32M
Insiders71.12%
Institutions0.74%
Short Interest
Short Ratio1.9d
Short % Float0.31%
Short % Out.0.15%
Shares Short12.57K
Short (prev mo.)10.67K
Technical
SMA 509.350 (+6.0%)
SMA 20011.28 (-12.2%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)3.56K
Avg Vol (10d)2.61K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—